10x Genomics Begins Commercial Shipments of Chromium GEM-X Products

March 13, 2024

https://www.prnewswire.com/news-releases/10x-genomics-begins-commercial-shipments-of-chromium-gem-x-products-302088504.html

The next generation of the company’s leading single cell technology architecture, GEM-X, enables higher performance at larger scale and lower cost

PLEASANTON, Calif., March 13, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping the first two products powered by the GEM-X technology architecture, Chromium Single Cell Gene Expression 3′ v4 and Chromium Single Cell Immune Profiling 5′ v3. GEM-X is the next generation of the company’s leading single cell technology architecture and is built on a new and improved microfluidic chip design, featuring the latest technological advancements and optimized reagents for superior performance and high reliability.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.